Patent · US Active

Thioindirubins

US11213510B2 · kind B2 · utility

0Cited by

0References

32Claims

0Family size

Assignees

City of Hope · US
National and Kapodistrian University of Athens · GR

Inventors

Sangkil Nam · Duarte, US
David Horne · Altadena, US
Ravi Salgia · Paddy Lane, US
Alexios Leandros Skaltsounis · Athens, GR
Nicolas Gaboriaud-Kolar · Athens, GR
Panagiotis Gerolymatos · Athens, GR
Nikolaos Lougiakis · Athens, GR

Key dates

Filing date	Aug 30, 2018
Grant date	Jan 4, 2022
Priority date	—
Expiry date	Sep 2, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein inter alia are compositions and methods for treating cancer using thioindirubin derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.